MDT Medtronic Plc

$MDT when Wall Street goes all in, this will go over $100. The move from low 70s to high 80s has been fantastic.

$MDT I doubled down my Medtronic holding based on the company continues improving its product lines, its business and ex dividend date today 3.25%. This stock is still quite undervaled. Load up now before Wall Street realizes it.

$MDT An Institution just bought oct 16 130c/p Straddle @ $42.50 ea (35,000 contracts). breakeven $87.5 Damn!

$MDT Barclays analyst Christopher Pasquale initiates coverage on Medtronic with a Equal-Weight rating and announces Price Target of $95.

$MDT holding all shares across all accounts and not taking the offer for discounted $MMED shares. I'll wait for this exchange to pass and then start looking into trading/investing into $MMED

$MDT Don't understand why it is going down the last 5 trading days. The other companies in the sector are going up. Positive news flow. It was close to a golden cross.

$MDT Hi All. I am a novice investor with a tiny holding here. I'm sure that opens this message up to a host of ridicule replies, but nevertheless, I trust this group ( to a certain extent). "Exchange Offer." This is new to me. I've done some quick superficial research, however, I am asking the board who has experience with this operation in this or other companies before and any thoughtful analysis of the terms associated with this new "offer." Grazie mille.

$MDT — Medtronic's strategic advancements, including platform development and a significant spin-off, were central to recent analyses, alongside technical indicators suggesting a bearish trend. Upside noted: Year-over-year quarterly revenue growth was 13.7%. Year-over-year quarterly earnings growth was 40.7%. Dividend yield of 3.28%. Current ratio of 2.067. Risk noted: Current price is below both the 50-day SMA and the 200-day SMA. RSI is below the neutral 50 level. MACD is below zero, indicating bearish momentum. Recent analyses examined Medtronic's strategic initiatives, including the advancement of its Altaviva and Symplicity Spyral platforms and the spin-off of its MiniMed division. The company's significant investment in robotics and its commitment to serving a large patient base were also noted. Technical indicators, such as SMAs and RSI, suggested a bearish short-to-medium term trend, despite some short-term upward momentum.

$MDT MMED will get put out of business by CRSP. Crisper technology will provide a cure. No wonder MDT is spinning it out.

$MDT $87.09 | Mixed / Sideways RSI 40.5 (Bearish) MACD Bearish | Vol 2.9x MA20 $89.96 | MA50 $90.07 MA200 $88.54 S $78.97 | R $95.41 Cap $111.40B P/E 21.4 | Fwd 13.6 Moderate Outlook | $84.39 (-3.1%)

🟢 $MDT 87C Oct 02 💰 $36,100 premium 💵 $0.55/contract 📊 106.5x Vol/OI 📍 Spot $86.43 🔥 106.5x Vol/OI | 🚨 Repeat sweep 🌊 Dark Flow | Options Flow

$MDT options flow lesson: chart and flow can disagree. Options activity describes the derivatives tape while the daily chart describes price structure. A disagreement is information, not an error to hide. The alert snapshot shows $54K in the Oct 9 $87 puts. Volume was 19.1x standing open interest at capture. Intraday volume does not establish whether a position was opened or held; the next settled open interest is the check.

$MDT Now is the time to double down medtroic. Jim Cramer's description of Medtronic as a quandary likely reflects that, despite improved results, the stock is still down 30% from its 2021 high. Its price-to-sales and price-to-earnings ratios are both below their five-year averages. Even after reporting strong fiscal first-quarter 2027 results, including nearly 14% revenue growth and a guidance raise after just a single quarter, Wall Street seems to still be stuck in a "show me" mood. That said, it looks like the company is already showing that it has turned a corner, but investors are not giving it any credit for the improvement. If you are a dividend lover, you might want to get to know Medtronic now, before Wall Street changes its mind. While investors can be poor judges of value over short periods, they tend to get things right over long periods. Taking advantage of "quandaries" like Medtronic can both increase the income you generate and lead to attractive long-term capital growth

$MDT they tryin to fake me out again. Just picked up an extra 50 shares here for the long

$MDT Horrible losses. Higher interest rates or something else? Other stocks in the same sector not hit nearly as much. Getting ready to sell, so you can expect a big gain tomorrow.

🟢 $MDT 92.5C Oct 16 💰 $63,800 premium 💵 $2.05/contract 📊 0.9x Vol/OI 📍 Spot $92.04 🚨 Repeat sweep 🌊 Dark Flow | Options Flow